In MS particularly, the presence (“leakage”) of the NFL subunit and its quantitative fluctuation in the serum/plasma emerges as a promising prognostic indicator to monitor neuro-axonal damage and disease progression [17,18,19]. The gene discussed is NEFL; the disease is myeloid sarcoma.